Exacerbation Rate in Generalized Myasthenia Gravis and Its Predictors

Abstract

More than half of newly diagnosed AChR + MG cases experience an exacerbation in the first 6 years. Gender, disease severity at onset and prednisone dose reduction are predictors that could inform clinical practice and future research.